Back to All Transactions

For more information regarding this transaction contact:
  • Mike Townley Investment Banking 213.536.0241

MiMedx Group, Inc. 

Lake Street is pleased to announce it served as co-managing underwriter for MiMedx Group, Inc. (NASDAQ: MDXG), a manufacturer and marketer of biomaterial-based products, in its public offering of 5,750,000 shares of common stock at a price of $6.80 per share.  Gross proceeds totaled $39M.

About MiMedx Group, Inc.

Headquartered in Marietta, Georgia, the Company operates as an integrated developer, manufacturer, and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane.  The Company sells its products through a combination of a direct sales force, independent stocking distributors, and representatives in the United Stated, as well as through independent distributors internationally.


Mike Townley
Head of Investment Banking


Email Mike

Dave McDonald
Head of Life Science Investment Banking


Email Dave


Tim Klein

Investment Banking


Email Tim


Rob Martin

Investment Banking


Email Rob


Steve Rickman

Investment Banking


Email Steve